-+ 0.00%
-+ 0.00%
-+ 0.00%

Avadel Pharmaceuticals Raises FY2025 Sales Guidance from $240.00M-$260.00M to $255.00M-$265.00M vs $330.28M Est

Benzinga·05/07/2025 11:08:45
Listen to the news
Avadel Pharmaceuticals (NASDAQ:AVDL) raises FY2025 sales outlook from $240.00 million-$260.00 million to $255.00 million-$265.00 million vs $330.28 million estimate.